Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In this prospective observational study we aim to determine the prevalence of oropharyngeal and rectal Gram-negative bacilli colonization in healthy subjects, and their susceptibility to chlorehexidine. We plan to recruit 100 healthy volunteers secondary endpoints are to determine the phylogentic characteristics of E. coli isolates; to compare the phylogentic characteristics of oropharyngeal and rectal of predominant GNB colonization.
In this prospective observational study we aim to determine the prevalence of oropharyngeal and rectal Gram-negative bacilli colonization in 100 healthy subjects, and their susceptibility to chlorehexidine. Each participant will undego a oropharyngeal swab collection and a rectal swab at day 0. The Gram-negative bacilli colonization will be identified, E. coli isolates will be studied in terms of phylogeny; gram-negative isolates will be studied in terms of antimicrobial and chlorhexidine susceptibility. The primary objective is to determine the prevalence of oropharyngeal Gram-negative bacilli colonization. The secondary objectives are to determine the chlorhexidine and antimicrobial susceptibility of such colonization; to determine the phylogentic characteristics of oropharyngeal and rectal predominant E. coli isolates; to compare the phylogentic characteristics of oropharyngeal and rectal E. coli isolates.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| healthy adult subject | oropharyngeal and rectal swabbing to collect Gram-negative bacilli |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| oropharyngeal swabbing | Other | microbiological sampling will be performed on buccal mucosa with standard swab. only one sample will be done |
|
| Measure | Description | Time Frame |
|---|---|---|
| proportion of patients with an oropharyngeal gram-negative colonization | Day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| incidence of the a GNB oropharyngeal colonization | Day 1 | |
| comparision of the predominant fecal flora with GNB oropharyngeal colonization | Day 1 | |
| characterization of antimicrobial and chlorhexidine susceptibility of Gram negative bacteria from oropharyngeal colonization |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
healthy volonteers
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jonathan MESSIKA, MD | Hopital Louis Mourier - Assistance Publique Hopitaux de Paris | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| AP-HP, Louis Mourier Hospital | Colombes | Île-de-France Region | 92700 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| rectal swabbing | Other | same process as oropharyngeal swabbing will be used to collect rectal microbiological sample |
|
| Day 1 |
| phylogenetic and virulence factor content of E. coli oropharyngeal and rectal colonization | Day 1 |